Shuangcheng Pharmaceutical announced on July 31 that on July 31, 2026, the company received a total of 2.3513 million yuan in government subsidies related to revenue, accounting for 12.35% of the company's latest audited net profit attributable to shareholders of listed companies. This government subsidy is in the form of cash, relates to the company's daily operating activities, and is not sustainable.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.